Search Results

9551 - 9575 of 56967
TitleWireDateTime
VirPoint Unveils Hybrid AI Division: Fusing Machine Precision with Elite Human Financial Expertise Globe Newswire 03/02 07:38
TEGNA Inc. Reports Fourth Quarter and Full-Year 2025 Results Globe Newswire 03/02 07:30
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 03/02 07:30
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM Globe Newswire 03/02 07:30
Wrap and WOFT Establish Drone Test & Non-Lethal Response Training Site in Florida Globe Newswire 03/02 07:30
Xanadu and Crane Harbor Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement Globe Newswire 03/02 07:30
Nexxen Announces February 2026 Share Repurchase Program Summary Globe Newswire 03/02 07:30
BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets Globe Newswire 03/02 07:30
Telkomsel Expands Capsyl Cloud Deployment with Synchronoss Globe Newswire 03/02 07:30
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone Globe Newswire 03/02 07:20
uniQure Announces 2025 Financial Results and Provides Recent Company Updates Globe Newswire 03/02 07:05
HBT Financial, Inc. Completes Merger with CNB Bank Shares, Inc. Globe Newswire 03/02 07:05
Xanadu and Crane Harbor Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement Globe Newswire 03/02 07:00
Beyond Binary: Qubic’s Neuraxon 2.0 Introduces a Trinary Architecture for Continuous, Adaptive AI Systems Globe Newswire 03/02 07:00
Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors Globe Newswire 03/02 07:00
U.S. Defense Logistics Agency Awards Historic Contract to REalloys’ Terves LLC to Scale Domestic Rare Earth Metal Production Globe Newswire 03/02 07:00
25% of Americans expect streaming discounts for binge-watching shows Globe Newswire 03/02 07:00
EyePoint Announces First Patients Dosed in Both Global Phase 3 Clinical Trials of DURAVYU™ for the Treatment of Diabetic Macular Edema Globe Newswire 03/02 07:00
NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer Globe Newswire 03/02 07:00
SPARC AI Appoints Matt McCrann as U.S. CEO Globe Newswire 03/02 07:00
NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference Globe Newswire 03/02 07:00
Intuitive Expands Investment and Footprint in Europe Globe Newswire 03/02 07:00
Due Diligence in Action: 1,000 Serious Supply Chain Issues Uncovered Weekly with SMETA Globe Newswire 03/02 07:00
GT Biopharma Reports Full Year 2025 Financial Results Globe Newswire 03/02 07:00
ADT Reports Fourth Quarter and Full Year 2025 Results; Announces New $1.5 Billion Share Repurchase Authorization Globe Newswire 03/02 06:55
9551 - 9575 of 56967

News, Photo and Web Search